Literature DB >> 10759568

SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage.

Y Mao1, M Sun, S D Desai, L F Liu.   

Abstract

Ubiquitin/26S proteasome-dependent degradation of topoisomerase I (TOP1) has been suggested to be a unique repair response to TOP1-mediated DNA damage. In the current study, we show that treatment of mammalian cells or yeast cells expressing human DNA TOP1 with camptothecin (CPT) induces covalent modification of the TOP1 by SUMO-1/Smt3p, a ubiquitin-like protein. This conclusion is based on the following observations: (i) Mammalian DNA TOP1 conjugates induced by CPT were cross-reactive with SUMO-1/Smt3p-specific antibodies both in yeast expressing human DNA TOP1 as well as mammalian cells. (ii) The formation of TOP1 conjugates was shown to be dependent on UBC9, the E2 enzyme for SUMO-1/Smt3p. (iii) TOP1 physically interacts with UBC9. (iv) Ubc9 mutant yeast cells expressing human DNA TOP1 was hypersensitive to CPT, suggesting that UBC9/SUMO-1 may be involved in the repair of TOP1-mediated DNA damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759568      PMCID: PMC18143          DOI: 10.1073/pnas.080536597

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

Authors:  M Gostissa; A Hengstermann; V Fogal; P Sandy; S E Schwarz; M Scheffner; G Del Sal
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

2.  SUMO-1 modification activates the transcriptional response of p53.

Authors:  M S Rodriguez; J M Desterro; S Lain; C A Midgley; D P Lane; R T Hay
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

Review 3.  Topoisomerase-targeting antitumor drugs: mechanisms of cytotoxicity and resistance.

Authors:  L F Liu; P D'Arpa
Journal:  Important Adv Oncol       Date:  1992

4.  Stimulation of intracellular topoisomerase I activity by vasopressin and thrombin. Differential regulation by pertussis toxin.

Authors:  P Nambi; M Mattern; J O Bartus; N Aiyar; S T Crooke
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

5.  Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

Authors:  T Andoh; K Ishii; Y Suzuki; Y Ikegami; Y Kusunoki; Y Takemoto; K Okada
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  DNA topoisomerase-targeting antitumor drugs can be studied in yeast.

Authors:  J Nitiss; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin.

Authors:  M A Bjornsti; P Benedetti; G A Viglianti; J C Wang
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

8.  The yeast DNA repair gene RAD6 encodes a ubiquitin-conjugating enzyme.

Authors:  S Jentsch; J P McGrath; A Varshavsky
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

Review 9.  Mechanism of induction of chromosomal aberrations by inhibitors of DNA topoisomerases.

Authors:  F Palitti
Journal:  Environ Mol Mutagen       Date:  1993       Impact factor: 3.216

10.  Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.

Authors:  P Pantazis; J T Mendoza; A DeJesus; E Rubin; D Kufe; B C Giovanella
Journal:  Eur J Haematol       Date:  1994-09       Impact factor: 2.997

View more
  59 in total

1.  Topoisomerase II can unlink replicating DNA by precatenane removal.

Authors:  I Lucas; T Germe; M Chevrier-Miller; O Hyrien
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  p53 stimulates human topoisomerase I activity by modulating its DNA binding.

Authors:  Kent Søe; Frank Grosse
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

3.  SUMO modified proteins localize to the XY body of pachytene spermatocytes.

Authors:  Richard S Rogers; Amy Inselman; Mary Ann Handel; Michael J Matunis
Journal:  Chromosoma       Date:  2004-09-03       Impact factor: 4.316

4.  Importin 13: a novel mediator of nuclear import and export.

Authors:  J M Mingot; S Kostka; R Kraft; E Hartmann; D Görlich
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

5.  Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.

Authors:  Stergios J Moschos; Yin-Yuan Mo
Journal:  J Mol Histol       Date:  2006-06-07       Impact factor: 2.611

6.  Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage.

Authors:  Emily A Andrews; Jan Palecek; John Sergeant; Elaine Taylor; Alan R Lehmann; Felicity Z Watts
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 7.  Human DNA topoisomerase I: relaxation, roles, and damage control.

Authors:  John B Leppard; James J Champoux
Journal:  Chromosoma       Date:  2005-04-14       Impact factor: 4.316

8.  Ubiquitin-family modifications of topoisomerase I in camptothecin-treated human breast cancer cells.

Authors:  Ragu Kanagasabai; Shujun Liu; Samir Salama; Edith F Yamasaki; Liwen Zhang; Kari B Greenchurch; Robert M Snapka
Journal:  Biochemistry       Date:  2009-04-14       Impact factor: 3.162

Review 9.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

10.  Transcription-dependent degradation of topoisomerase I-DNA covalent complexes.

Authors:  Shyamal D Desai; Hui Zhang; Alexandra Rodriguez-Bauman; Jin-Ming Yang; Xiaohua Wu; Murugesan K Gounder; Eric H Rubin; Leroy F Liu
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.